The effects of norepinephrine and propranolol on myocardial subcellular distribution of triglycerides and free fatty acids.
D000818:Animals; D002247:Carbon Isotopes; D006328:Cardiac Catheterization; D002467:Cell Nucleus / Q000032:analysis; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000032:analysis / Q000378:metabolism*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D008861:Microsomes / Q000032:analysis; D008931:Mitochondria, Muscle / Q000032:analysis; D009206:Myocardium / Q000032:analysis / Q000166:cytology / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology*; D010169:Palmitic Acids / Q000032:analysis / Q000378:metabolism; D010743:Phospholipids / Q000032:analysis; D011433:Propranolol / Q000494:pharmacology*; D014280:Triglycerides / Q000032:analysis / Q000378:metabolism*; D014461:Ultracentrifugation
D002247:Carbon Isotopes; D005230:Fatty Acids, Nonesterified; D010169:Palmitic Acids; D010743:Phospholipids; D014280:Triglycerides; D011433:Propranolol; D009638:Norepinephrine